Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study
Martine Vaxillaire 1 ,
Jacques Veslot 1 ,
Christian Dina 1 ,
Christine Proença 1 ,
Stéphane Cauchi 1 ,
Guillaume Charpentier 2 ,
Jean Tichet 3 ,
Frédéric Fumeron 4 5 ,
Michel Marre 4 5 6 ,
David Meyre 1 ,
Beverley Balkau 7 8 ,
Philippe Froguel 1 9 and
for the DESIR Study Group
1 UMR8090 and Institute of Biology, Lille 2 University, CNRS and Pasteur Institute, Lille, France
2 Department of Endocrinology-Diabetology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France
3 Regional Institute for Health, Tours, France
4 INSERM U695, Paris, Francem
5 Université Paris Diderot, Paris, France
6 Department of Endocrinology-Diabetology and Nutrition, Bichat Claude Bernard Hospital, Paris, France
7 INSERM U780-IFR69, Villejuif, France
8 University of Paris-Sud, Villejuif, France
9 Department of Genomic Medicine, Hammersmith Hospital, Imperial College London, London, U.K
Address correspondence and reprint requests to Dr. Martine Vaxillaire, CNRS UMR8090, Institut Pasteur de Lille, 1 rue du Professeur
Calmette, BP 245, 59019 Lille, France. E-mail: martine.vaxillaire{at}good.ibl.fr
Abstract
OBJECTIVE— The emerging picture of type 2 diabetes genetics involves differently assembled gene variants, each modestly increasing risk
with environmental exposure. However, the relevance of these genes for disease prediction has not been extensively tested.
RESEARCH DESIGN AND METHODS— We analyzed 19 common polymorphisms of 14 known candidate genes for their contribution to prevalence and incidence of glucose
intolerance in the DESIR (Data from an Epidemiological Study on the Insulin Resistance syndrome) prospective study of middle-aged
Caucasian subjects, including 3,877 participants (16.8% with hyperglycemia and 7.9% with diabetes after the 9-year study).
RESULTS— The GCK ( Glucokinase ) −30A allele was associated with increased type 2 diabetes risk at the end of the follow-up study (adjusted OR 1.34 [95%
CI 1.07–1.69]) under an additive model, as supported in independent French diabetic case subjects (OR 1.22, P = 0.007), with increased fasting glycemia (0.85% per A allele, P = 6 × 10 −5 ) and decreased homeostasis model assessment of β-cell function (4%, P = 0.0009). IL6 ( Interleukin- 6 ) −174 G/C interacts with age in disease risk and modulates fasting glycemia according to age (1.36% decrease over 56 years,
P = 5 × 10 −5 ). These polymorphisms together with KCNJ11 (Kir6.2)-E23K and TCF7L2 -rs7903146 may predict diabetes incidence in the DESIR cohort. Each additional risk allele at GCK , TCF7L2 , and IL6 increased risk by 1.34 ( P = 2 × 10 −6 ), with an OR of 2.48 (95% CI 1.59–3.86), in carriers of at least four at-risk alleles compared with those with none or one
risk allele.
CONCLUSIONS— Our data confirm several at-risk polymorphisms for type 2 diabetes in a general population and demonstrate that prospective
studies are valuable designs to complement classical genetic approaches.
AUC, area under the curve
DESIR, Data from an Epidemiological Study on the Insulin Resistance syndrome
FPG, fasting plasma glucose
HOMA, homeostasis model assessment
HOMA-B, HOMA of β-cell function
HOMA-IR, HOMA of insulin resistance
IFG, impaired fasting glycemia
IL, interleukin
MAF, minor allele frequency
ROC, receiver operating characteristic
SNP, single nucleotide polymorphism
Footnotes
Published ahead of print at http://diabetes.diabetesjournals.org on 31 October 2007. DOI: 10.2337/db07-0615.
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-0615 .
The costs of publication of this article were defrayed in part by the payment of page charges. This article must...

Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study

10.2337/db07-0615